<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>An impairment of <z:chebi fb="105" ids="17234">glucose</z:chebi>-stimulated insulin secretion--reflecting decreased glucokinase expression--and a moderate decrease in beta cell mass attributable to <z:mp ids='MP_0006042'>increased apoptosis</z:mp>, constitute the key features of beta cell failure in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain><z:mp ids='MP_0003674'>Oxidative stress</z:mp>, provoked by prolonged exposure to excessive levels of <z:chebi fb="105" ids="17234">glucose</z:chebi> and/or fatty acids (glucolipotoxicity), appears to be a key mediator of these defects </plain></SENT>
<SENT sid="2" pm="."><plain>Oxidant-provoked JNK activation induces nuclear export of the PDX-1 transcription factor, required for expression of glucokinase and other beta cell proteins </plain></SENT>
<SENT sid="3" pm="."><plain>Conversely, increases in cAMP induced by incretin hormones promote the nuclear importation of PDX-1, counteracting the diabetogenic impact of oxidant stress; this may explain the utility of measures that slow dietary carbohydrate absorption for <z:mp ids='MP_0002055'>diabetes</z:mp> prevention </plain></SENT>
<SENT sid="4" pm="."><plain>The ability of <z:mp ids='MP_0003674'>oxidative stress</z:mp> to boost <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in beta cells is poorly understood, but may also entail JNK activation </plain></SENT>
<SENT sid="5" pm="."><plain>Recent work establishes a phagocyte-type <z:chebi fb="1" ids="16474">NADPH</z:chebi> oxidase as the chief source of glucotoxicity-mediated <z:mp ids='MP_0003674'>oxidative stress</z:mp> in beta cells </plain></SENT>
<SENT sid="6" pm="."><plain>Since <z:chebi fb="0" ids="16990">bilirubin</z:chebi> is now known to function physiologically as an inhibitor of <z:chebi fb="1" ids="16474">NADPH</z:chebi> oxidase, and phycocyanobilin (PCB) derived from spirulina likewise can inhibit this enzyme complex, supplemental PCB may have utility in the prevention and control of <z:mp ids='MP_0002055'>diabetes</z:mp>, and <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert syndrome</z:e>, associated with chronically elevated free <z:chebi fb="0" ids="16990">bilirubin</z:chebi>, may be associated with decreased <z:mp ids='MP_0002055'>diabetes</z:mp> risk </plain></SENT>
</text></document>